UNSPSC 51171647: Bisacodyl tannex

This classification denotes a laxative C76H52O46.C22H19NO4, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier T0I8L1B7J6, chemically known as er-soluble complex of bisacodyl and tannic acid. (1) phenol, 4,4'-(2-pyridinylmethylene)bis-, diacetate (ester), complex with tannic acid, but more generally known as bisacodyl tannex, which bears US NIH Compound Identifier 2391. Most nations, for tariff and trade purposes, schedule bisacodyl tannex under HS 29333999 and SITC 51574.

SMILES: As of Q4 2014, BISACODYL TANNEX remains US FDA's Preferred Term for this commodity.

UNSPSC 51171647 Bisacodyl tannex is a Commodity code representing a specific pharmaceutical active ingredient or formulation. State and local procurement activity under this code centers on pharmaceutical acquisition through multiple channels: direct procurement by health and human services agencies, cooperative purchasing agreements, and vendor services supporting pharmacy benefit programs. The issuing bodies include state health departments, county departments of corrections and supervision, and multistate cooperative purchasing alliances serving state agencies and local government facilities. Work being solicited encompasses generic pharmaceutical supply contracts with detailed NDC and SKU specifications, direct-to-manufacturer prescription program capability assessments, and drug testing services (which may incidentally involve pharmaceutical screening reagents or confirmation methodologies aligned with pharmaceutical supply chain standards). The mix reflects both centralized state procurement and decentralized county-level corrections and supervision demand.

Recent activity spans Texas and Minnesota with multistate reach through cooperative vehicles. The Minnesota Multistate Cooperative Purchasing Alliance (MMCAP) issued RFP S1070000015802 on January 20, 2026 (due March 26, 2026) for generic multi-source pharmaceuticals and OTC products distributed across participating state and local facilities including Oregon, requiring NDC-specific submissions through AmerisourceBergen, Cardinal Health, and Morris & Dickson wholesalers. The Texas Health and Human Services Commission issued RFI HHS0017013 (April 3, 2026) to explore direct-to-manufacturer prescription program capabilities and vendor contracting models. Collin County Community Supervision and Corrections Department posted RFP 2026-327 on July 9, 2026 (due July 23, 2026) for offender specimen collection and drug testing services valued at $600,000 over two years, encompassing approximately 25,031 annual tests with immunoassay screening and LC/MS/MS or GC/MS confirmation methodologies requiring SAMHSA, Texas DPS, or CAP lab certification. The code shows modest recent activity concentrated in state-level cooperative purchasing and county corrections demand rather than broad multistate distribution across all state and local jurisdictions.